AHA, others urge Senate HELP Committee to advance MEDS Act (S.2723).
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA comments to the聽U.S. House of Representatives Committee on Education and Labor on provisions of the聽Ban Surprise Billing Act that will be marked up this week.
The AHA is pleased to support the U.S. House of Representatives Committee on Ways and Means legislation, the Consumer Protections Against Surprise Medical Bills Act of 2020.聽
AHA comments on the Centers for Medicare & Medicaid Services鈥 proposed regulation related to Medicaid program financing and supplemental payments.
AHA comments to CMS聽on the transparency in coverage proposed rule. The AHA appreciates the Departments of the Treasury, Labor, and Health and Human Services鈥 (collectively, the departments) effort to increase the availability of useful information for patients, specifically, the proposal to improve patient access to estimates of their individual cost-sharing liability prior to care.
A model comment letter on聽Proposed Rule: CMS鈥2393鈥揚, Medicaid Program: Medicaid Fiscal Accountability Regulation (Vol. 84, No. 222), November 18, 2019 and CMS-2393-N (Vol. 84, No. 249) December 30, 2019, and the聽infographic "Financial Impact Analysis: Proposed Medicaid Fiscal Accountability Rule (MFAR) Could Result in Deep Medicaid Cuts."
The Medicare Payment Advisory Commission (MedPAC, or the Commission) will vote this month on payment recommendations for 2021.
The AHA commented on the Food and Drug Administration鈥檚 draft guidance for industry and FDA staff on clinical decision support software as part of the agency鈥檚 efforts to implement Section 3060(a) of the 21st Century Cures Act.
AHA urges CMS to reconsider its recent guidance to providers requiring them to document Medicare-Medicaid 鈥渃rossover鈥 bad debt in a manner that is neither standard practice for most hospitals nor consistent with current accounting standards.
By proposing a new safe harbor for patient engagement tools and creating three new safe harbors for value-based arrangements, the Department of Health and Human Services Office of Inspector General has taken 鈥渢he first steps toward much needed reform鈥 of the federal anti-kickback statute and civil monetary penalty rules regarding beneficiary inducements,